simple obo diffs creates duplicate Classes added

[hrshdhgd]

I ran runoak -i simpleobo:hp.obo diff -X simpleobo:hp-latest.obo -o diff.md -O md and the Classes added section looked like this:

Classes added: 932

Term
Mosaic attenuation pattern in lung (HP:6000317)
Mosaic attenuation pattern in lung (HP:6000317)
Increased circulating interleukin 1beta concentration (HP:6000374)
Increased circulating interleukin 1beta concentration (HP:6000374)
Reduced tissue medium-chain acyl-CoA dehydrogenase activity (HP:6000356)
Reduced tissue medium-chain acyl-CoA dehydrogenase activity (HP:6000356)
Reduced succinyl-CoA:3-oxoacid-CoA transferase activity in cultured fibroblasts (HP:6000361)
Reduced succinyl-CoA:3-oxoacid-CoA transferase activity in cultured fibroblasts (HP:6000361)
Parietal cortex localization (HP:0430131)
Parietal cortex localization (HP:0430131)
Elevated urinary saccharopine level (HP:6000283)
Elevated urinary saccharopine level (HP:6000283)
Elevated natural killer cell count (HP:6000677)
Elevated natural killer cell count (HP:6000677)
Loose body in joint (HP:6000591)
Loose body in joint (HP:6000591)
Elevated muscle fiber laminin alpha 5 expression (HP:6000659)
Elevated muscle fiber laminin alpha 5 expression (HP:6000659)
Anti-polio virus antibody positivity (HP:6000346)
Anti-polio virus antibody positivity (HP:6000346)
Positive oropharangeal infectious agent test (HP:6000579)
Positive oropharangeal infectious agent test (HP:6000579)
Elevated circulating vasoactive intestinal peptide concentration (HP:6000564)
Elevated circulating vasoactive intestinal peptide concentration (HP:6000564)
Positive synovial fluid gram stain (HP:6000583)
Positive synovial fluid gram stain (HP:6000583)
Elevated blood ethylene glycol concentration (HP:6000568)
Elevated blood ethylene glycol concentration (HP:6000568)
Exacerbated by opiate medication (HP:6000634)
Exacerbated by opiate medication (HP:6000634)
Penile corporal blood gas ischemia (HP:6000625)
Penile corporal blood gas ischemia (HP:6000625)
Elevated circulating calprotectin concentration (HP:6000502)
Elevated circulating calprotectin concentration (HP:6000502)
Anti-factor IX antibody positivity (HP:6000495)
Anti-factor IX antibody positivity (HP:6000495)
Tobacco use history (HP:0430133)
Tobacco use history (HP:0430133)
Reduced circulating interleukin 12 concentration (HP:6000487)
Reduced circulating interleukin 12 concentration (HP:6000487)
Pancreatic arteriovenous malformation (HP:6000379)
Pancreatic arteriovenous malformation (HP:6000379)
Coprolalia (HP:0430112)
Coprolalia (HP:0430112)
Reduced Acyl-CoA:dihydroxyacetone phosphate acyltransferase activity in cultured fibroblasts (HP:6000426)
Reduced Acyl-CoA:dihydroxyacetone phosphate acyltransferase activity in cultured fibroblasts (HP:6000426)
Elevated urinary porphyrin level (HP:6000535)
Elevated urinary porphyrin level (HP:6000535)
Elevated urinary ureidopropionic acid level (HP:6000534)
Elevated urinary ureidopropionic acid level (HP:6000534)
Frontalis muscle overactivity (HP:0430144)
Frontalis muscle overactivity (HP:0430144)
Anti-coagulation factor antibody positivity (HP:6000351)
Anti-coagulation factor antibody positivity (HP:6000351)
Right ventricular regional wall motion abnormality (HP:6000664)
Right ventricular regional wall motion abnormality (HP:6000664)
Decreased circulating nicotinamide adenine dinucleotide concentration (HP:6000405)
Decreased circulating nicotinamide adenine dinucleotide concentration (HP:6000405)
Rheumatoid nodule (HP:6000418)
Rheumatoid nodule (HP:6000418)
Bartholin cyst (HP:0430134)
Bartholin cyst (HP:0430134)
Splenic calcification (HP:6000381)
Splenic calcification (HP:6000381)
Decreased CSF N-acetylaspartic acid concentration (HP:6000674)
Decreased CSF N-acetylaspartic acid concentration (HP:6000674)
Abnormal serum osmolality (HP:6000679)
Abnormal serum osmolality (HP:6000679)
Elevated circulating lipoprotein(a) concentration (HP:6000521)
Elevated circulating lipoprotein(a) concentration (HP:6000521)
Blunted aldosterone response to aldosterone suppression test (HP:6000362)
Blunted aldosterone response to aldosterone suppression test (HP:6000362)
Elevated urinary 3-hydroxyisobutyric acid level (HP:6000607)
Elevated urinary 3-hydroxyisobutyric acid level (HP:6000607)
Elevated urinary gamma-glutamylphenylalanine level (HP:6000281)
Elevated urinary gamma-glutamylphenylalanine level (HP:6000281)
Elevated urinary N-tau-ribosylhistidine level (HP:6000621)
Elevated urinary N-tau-ribosylhistidine level (HP:6000621)
Orbital inflammation (HP:6000614)
Orbital inflammation (HP:6000614)
Prevertebral space enlargement (HP:6000290)
Prevertebral space enlargement (HP:6000290)
Ectopic testis (HP:6000460)
Ectopic testis (HP:6000460)
Elevated circulating aspartylglucosamine concentration (HP:6000282)
Elevated circulating aspartylglucosamine concentration (HP:6000282)
3-5 finger cutaneous syndactyly (HP:6000505)
3-5 finger cutaneous syndactyly (HP:6000505)
Ecrrine sweat gland predominance (HP:6000537)
Ecrrine sweat gland predominance (HP:6000537)
Positive Dengue virus PCR test in the blood circulation (HP:6000551)
Positive Dengue virus PCR test in the blood circulation (HP:6000551)
History of abdominal surgery (HP:6000311)
History of abdominal surgery (HP:6000311)
Distal tibiofibular synostosis (HP:6000650)
Distal tibiofibular synostosis (HP:6000650)
Exposure to cosmetic fragrances (HP:6000636)
Exposure to cosmetic fragrances (HP:6000636)
Elevated urinary succinylacetone level (HP:6000598)
Elevated urinary succinylacetone level (HP:6000598)
Reduced circulating alpha-1,3-fucosyltransferase activity (HP:6000512)
Reduced circulating alpha-1,3-fucosyltransferase activity (HP:6000512)
Abnormal circulating interleukin 12 concentration (HP:6000442)
Abnormal circulating interleukin 12 concentration (HP:6000442)
Prenatal flattened diaphragm (HP:6000340)
Prenatal flattened diaphragm (HP:6000340)
Reduced alkyl-dihydroxyacetonephosphate synthase activity in cultured fibroblasts (HP:6000427)
Reduced alkyl-dihydroxyacetonephosphate synthase activity in cultured fibroblasts (HP:6000427)
Dilated ejaculatory duct (HP:6000471)
Dilated ejaculatory duct (HP:6000471)
Elevated circulating oxalate concentration (HP:6000567)
Elevated circulating oxalate concentration (HP:6000567)
Intradural spinal lipoma (HP:6000415)
Intradural spinal lipoma (HP:6000415)
Anti-lamin C antibody positivity (HP:6000644)
Anti-lamin C antibody positivity (HP:6000644)
Recent temporal region trauma (HP:6000626)
Recent temporal region trauma (HP:6000626)
Decreased FOXP3-expressing T cell count (HP:6000473)
Decreased FOXP3-expressing T cell count (HP:6000473)
Reduced muscle glycogen phosphorylase activity (HP:6000358)
Reduced muscle glycogen phosphorylase activity (HP:6000358)
Elevated urine propionic acid level (HP:6000432)
Elevated urine propionic acid level (HP:6000432)
Jugular foramen stenosis (HP:6000376)
Jugular foramen stenosis (HP:6000376)
Mallory bodies (HP:6000457)
Mallory bodies (HP:6000457)
Rectal duplication (HP:6000336)
Rectal duplication (HP:6000336)
Anti-prothrombin antibody positivity (HP:6000491)
Anti-prothrombin antibody positivity (HP:6000491)
Positive human Immunodeficiency virus nucleic acid test in the blood circulation (HP:6000546)
Positive human Immunodeficiency virus nucleic acid test in the blood circulation (HP:6000546)
Abnormal circulating hepatic transaminase concentration (HP:0430135)
Abnormal circulating hepatic transaminase concentration (HP:0430135)
Abnormal urinary bile acid level (HP:6000524)
Abnormal urinary bile acid level (HP:6000524)
Reduced erythrocyte adenylate kinase activity (HP:6000558)
Reduced erythrocyte adenylate kinase activity (HP:6000558)
Elevated urine N-acetyltyrosine level (HP:6000479)
Elevated urine N-acetyltyrosine level (HP:6000479)
Elevated urinary isovaleric acid level (HP:6000434)
Elevated urinary isovaleric acid level (HP:6000434)
Reduced tissue mannosyl-oligosaccharide glucosidase activity (HP:6000576)
Reduced tissue mannosyl-oligosaccharide glucosidase activity (HP:6000576)
Mucus in stool (HP:6000686)
Mucus in stool (HP:6000686)
Incomplete right bundle branch block (HP:6000313)
Incomplete right bundle branch block (HP:6000313)
Reduced tissue UDP-glucuronyl-transferase activity (HP:6000617)
Reduced tissue UDP-glucuronyl-transferase activity (HP:6000617)
Thickened Descemet membrane (HP:6000312)
Thickened Descemet membrane (HP:6000312)
Sleep drunkeness (HP:6000456)
Sleep drunkeness (HP:6000456)
Myositis-specific autoantibody positivity (HP:6000678)
Myositis-specific autoantibody positivity (HP:6000678)
Breast myxoma (HP:6000671)
Breast myxoma (HP:6000671)
Ectopic gallstone (HP:6000455)
Ectopic gallstone (HP:6000455)
Breast granuloma (HP:6000635)
Breast granuloma (HP:6000635)
Difficulty passing nasogastric tube (HP:6000294)
Difficulty passing nasogastric tube (HP:6000294)
Muscle arteriovenous malformation (HP:6000586)
Muscle arteriovenous malformation (HP:6000586)
Anti-human ferritin peptide antibody positivity (HP:6000508)
Anti-human ferritin peptide antibody positivity (HP:6000508)
Reduced erythrocyte uroporphyrinogen III cosynthase activity (HP:6000514)
Reduced erythrocyte uroporphyrinogen III cosynthase activity (HP:6000514)
History of compressive dressings (HP:6000682)
History of compressive dressings (HP:6000682)
Reduced sympathoneural responses to the cold pressor test (HP:6000323)
Reduced sympathoneural responses to the cold pressor test (HP:6000323)
Elevated monolysocardiolipin/cardiolipin ratio (HP:6000517)
Elevated monolysocardiolipin/cardiolipin ratio (HP:6000517)
Posiitive mycobacterium CSF culture (HP:6000543)
Posiitive mycobacterium CSF culture (HP:6000543)
Umbilical cord prolapse (HP:6000329)
Umbilical cord prolapse (HP:6000329)
Elevated urinary 3,4-Dihydroxybutyric acid level (HP:6000608)
Elevated urinary 3,4-Dihydroxybutyric acid level (HP:6000608)
Absent zona pellucida (HP:6000328)
Absent zona pellucida (HP:6000328)
Forearm (HP:6000299)
Forearm (HP:6000299)
Jaw mass (HP:6000307)
Jaw mass (HP:6000307)
Anti-erythrocyte autoantibody positivity (HP:6000388)
Anti-erythrocyte autoantibody positivity (HP:6000388)
Reduced circulating fibroblast growth factor 23 concentration (HP:6000488)
Reduced circulating fibroblast growth factor 23 concentration (HP:6000488)
Elevated red cell pyruvate kinase activity (HP:6000561)
Elevated red cell pyruvate kinase activity (HP:6000561)
Focal T1 hyperintense brainstem lesion (HP:6000286)
Focal T1 hyperintense brainstem lesion (HP:6000286)
Elevated urinary quinolinic acid level (HP:6000335)
Elevated urinary quinolinic acid level (HP:6000335)
Snapping sensation at metacarpophalangeal joint (HP:6000298)
Snapping sensation at metacarpophalangeal joint (HP:6000298)
Anti Parvovirus antibody positivity (HP:6000584)
Anti Parvovirus antibody positivity (HP:6000584)
Elevated blood mercury concentration (HP:6000443)
Elevated blood mercury concentration (HP:6000443)
Elevated circulating lysophosphatidylcholine concentration (HP:6000403)
Elevated circulating lysophosphatidylcholine concentration (HP:6000403)
Positive CSF JC-virus nucleic acid test (HP:6000552)
Positive CSF JC-virus nucleic acid test (HP:6000552)
Supernumerary tarsal bone (HP:6000593)
Supernumerary tarsal bone (HP:6000593)
Elevated urinary 2-methyl-3-hydroxybutyric acid level (HP:6000603)
Elevated urinary 2-methyl-3-hydroxybutyric acid level (HP:6000603)
Continuous involuntary vocalizations (HP:0430113)
Continuous involuntary vocalizations (HP:0430113)
Positive CSF nucleic acid pathogen test (HP:0430140)
Positive CSF nucleic acid pathogen test (HP:0430140)
Elevated erythrocyte inosine triphosphate concentration (HP:6000510)
Elevated erythrocyte inosine triphosphate concentration (HP:6000510)
Elevated brain guanidinoacetate level by MRS (HP:6000484)
Elevated brain guanidinoacetate level by MRS (HP:6000484)
Ovarian cystadenoma (HP:6000672)
Ovarian cystadenoma (HP:6000672)
High serum osmolality (HP:6000681)
High serum osmolality (HP:6000681)
Elevated myocardial iron load (HP:6000663)
Elevated myocardial iron load (HP:6000663)
Elevated urinary histamine level (HP:6000532)
Elevated urinary histamine level (HP:6000532)
3-4 toe cutaneous syndactyly (HP:6000648)
3-4 toe cutaneous syndactyly (HP:6000648)
Anti-factor VII antibody positivity (HP:6000493)
Anti-factor VII antibody positivity (HP:6000493)
Sunflower cataract (HP:6000642)
Sunflower cataract (HP:6000642)
Recent foraged mushroom consumption (HP:6000304)
Recent foraged mushroom consumption (HP:6000304)
Brain parenchymal tuberculoma (HP:6000585)
Brain parenchymal tuberculoma (HP:6000585)
Reduced circulating aspartate aminotransferase concentration (HP:0430136)
Reduced circulating aspartate aminotransferase concentration (HP:0430136)
Reduced urinary manganese level (HP:6000481)
Reduced urinary manganese level (HP:6000481)
Decreased CSF 3-methoxy-4-hydroxyphenylglycolaldehyde concentration (HP:6000398)
Decreased CSF 3-methoxy-4-hydroxyphenylglycolaldehyde concentration (HP:6000398)
Reduced circulating squalene concentration (HP:6000440)
Reduced circulating squalene concentration (HP:6000440)
Elevated circulating ghrelin concentration (HP:6000436)
Elevated circulating ghrelin concentration (HP:6000436)
CSF oligoclonal immunoglobulin G bands (HP:6000397)
CSF oligoclonal immunoglobulin G bands (HP:6000397)
Reduced CSF creatine concentration (HP:6000400)
Reduced CSF creatine concentration (HP:6000400)
T2 hyperintense cerebellar lesion (HP:6000416)
T2 hyperintense cerebellar lesion (HP:6000416)
Failure to elevate lactate upon ischemic exercise test (HP:6000526)
Failure to elevate lactate upon ischemic exercise test (HP:6000526)
Perimenopausal onset (HP:6000314)
Perimenopausal onset (HP:6000314)
Labile Hypertension (HP:6000321)
Labile Hypertension (HP:6000321)
Proximal to distal progression (HP:6000305)
Proximal to distal progression (HP:6000305)
Anti-factor VIII antibody positivity (HP:6000494)
Anti-factor VIII antibody positivity (HP:6000494)
Subchondral fracture (HP:6000287)
Subchondral fracture (HP:6000287)
Anti-beta fodrin antibody positivity (HP:6000475)
Anti-beta fodrin antibody positivity (HP:6000475)
Right ventricular regional akinesia (HP:6000665)
Right ventricular regional akinesia (HP:6000665)
Anti-vinculin antibody positivity (HP:6000645)
Anti-vinculin antibody positivity (HP:6000645)
Elevated CSF alpha-crystallin B chain concentration (HP:6000399)
Elevated CSF alpha-crystallin B chain concentration (HP:6000399)
Seminal vesicle agenesis (HP:0430121)
Seminal vesicle agenesis (HP:0430121)
Squamosal suture synostosis (HP:6000612)
Squamosal suture synostosis (HP:6000612)
Positive mycobacterium CSF microscopy (HP:6000544)
Positive mycobacterium CSF microscopy (HP:6000544)
Elevated CSF beta-alanine concentration (HP:6000277)
Elevated CSF beta-alanine concentration (HP:6000277)
Reduced muscle 6-phosphofructokinase activity (HP:6000359)
Reduced muscle 6-phosphofructokinase activity (HP:6000359)
Reduced erythrocyte inosine triphosphatase activity (HP:6000511)
Reduced erythrocyte inosine triphosphatase activity (HP:6000511)
Posterior fossa localization (HP:0430129)
Posterior fossa localization (HP:0430129)
Tectal plate enlargement (HP:6000284)
Tectal plate enlargement (HP:6000284)
Renal tubular karyomegaly (HP:6000429)
Renal tubular karyomegaly (HP:6000429)
Increased urinary bile acid level (HP:6000523)
Increased urinary bile acid level (HP:6000523)
Kerion (HP:6000424)
Kerion (HP:6000424)
Increased circulating inhibin B concentration (HP:6000520)
Increased circulating inhibin B concentration (HP:6000520)
Positive bloodstream infectious agent antigen test (HP:0430109)
Positive bloodstream infectious agent antigen test (HP:0430109)
Diminished neutrophil myeloperoxidase activity (HP:6000513)
Diminished neutrophil myeloperoxidase activity (HP:6000513)
Elevated circulating D-glyceric concentration (HP:6000371)
Elevated circulating D-glyceric concentration (HP:6000371)
Anti-ADAMTS13 antibody positivity (HP:6000462)
Anti-ADAMTS13 antibody positivity (HP:6000462)
Phlebolith (HP:6000661)
Phlebolith (HP:6000661)
Nasal secretion eosinophilia (HP:0430119)
Nasal secretion eosinophilia (HP:0430119)
Gastrocnemius contracture (HP:6000366)
Gastrocnemius contracture (HP:6000366)
Positive skin fungus test (HP:0430118)
Positive skin fungus test (HP:0430118)
Increased circulating interleukin 15 concentration (HP:6000439)
Increased circulating interleukin 15 concentration (HP:6000439)
Pneumobilia (HP:6000454)
Pneumobilia (HP:6000454)
Anti-factor XIII antibody positivity (HP:6000498)
Anti-factor XIII antibody positivity (HP:6000498)
Third cranial nerve thickening (HP:6000291)
Third cranial nerve thickening (HP:6000291)
Past surgical history (HP:0430103)
Past surgical history (HP:0430103)
Glomerular PLA2R immune-complex deposition (HP:6000669)
Glomerular PLA2R immune-complex deposition (HP:6000669)
CHANGE ME (HP:6000380)
CHANGE ME (HP:6000380)
Epiglottic enlargement (HP:6000289)
Epiglottic enlargement (HP:6000289)
Elevated urinary pyrroline hydroxycarboxylic acid level (HP:6000620)
Elevated urinary pyrroline hydroxycarboxylic acid level (HP:6000620)
Elevated CSF 14-3-3 protein concentration (HP:6000689)
Elevated CSF 14-3-3 protein concentration (HP:6000689)
Rotational fracture (HP:6000300)
Rotational fracture (HP:6000300)
Deep neck abscess (HP:6000288)
Deep neck abscess (HP:6000288)
Positive CSF enterovirus nucleic acid test (HP:6000547)
Positive CSF enterovirus nucleic acid test (HP:6000547)
Abnormal ischium ossification (HP:6000654)
Abnormal ischium ossification (HP:6000654)
Positive stool Giardia antigen test (HP:6000324)
Positive stool Giardia antigen test (HP:6000324)
Anti-human immunodeficiency virus antibody positivity (HP:6000345)
Anti-human immunodeficiency virus antibody positivity (HP:6000345)
Poly-hill sign (HP:6000504)
Poly-hill sign (HP:6000504)
Reduced tissue carnitine-acylcarnitine translocase activity (HP:6000574)
Reduced tissue carnitine-acylcarnitine translocase activity (HP:6000574)
Gastric perforation (HP:6000383)
Gastric perforation (HP:6000383)
Elevated circulating CCL4 concentration (HP:6000688)
Elevated circulating CCL4 concentration (HP:6000688)
Small fetal abdominal circumference (HP:6000339)
Small fetal abdominal circumference (HP:6000339)
Positive respiratory tract infectious agent test (HP:0430151)
Positive respiratory tract infectious agent test (HP:0430151)
Reduced circulating dopamine beta-hydroxylase activity (HP:6000556)
Reduced circulating dopamine beta-hydroxylase activity (HP:6000556)
Ameliorated by gastric acid-reducing therapy (HP:6000350)
Ameliorated by gastric acid-reducing therapy (HP:6000350)
Extremities cold to touch (HP:6000500)
Extremities cold to touch (HP:6000500)
High-pitched bowel sounds (HP:6000633)
High-pitched bowel sounds (HP:6000633)
Central thinning of the outer nuclear layer of the retina (HP:6000367)
Central thinning of the outer nuclear layer of the retina (HP:6000367)
Positive bloodstream plasmodium falciparum nucleic acid pathogen test (HP:6000554)
Positive bloodstream plasmodium falciparum nucleic acid pathogen test (HP:6000554)
Elevated urine 3-methyladipic acid level (HP:6000466)
Elevated urine 3-methyladipic acid level (HP:6000466)
Anti-desmocollin antibody positivity (HP:6000448)
Anti-desmocollin antibody positivity (HP:6000448)
Bone arteriovenous malformation (HP:6000587)
Bone arteriovenous malformation (HP:6000587)
Decreased circulating catecholamine concentration (HP:6000482)
Decreased circulating catecholamine concentration (HP:6000482)
Cervical hypoplasia (HP:0430115)
Cervical hypoplasia (HP:0430115)
Elevated circulating cholestanol concentration (HP:6000527)
Elevated circulating cholestanol concentration (HP:6000527)
Delayed scintigraphic gallbladder filling (HP:6000378)
Delayed scintigraphic gallbladder filling (HP:6000378)
Anti-NR2A antibody positivity (HP:6000347)
Anti-NR2A antibody positivity (HP:6000347)
Poorly demarcated skin lesion (HP:6000538)
Poorly demarcated skin lesion (HP:6000538)
Reduced tissue aspartylglucosaminidase activity (HP:6000573)
Reduced tissue aspartylglucosaminidase activity (HP:6000573)
Enlarged fetal lungs (HP:6000613)
Enlarged fetal lungs (HP:6000613)
Anti-factor H antibody positivity (HP:6000499)
Anti-factor H antibody positivity (HP:6000499)
Meteorism (HP:6000319)
Meteorism (HP:6000319)
PAS-positive lymphocyte vacuolization (HP:6000639)
PAS-positive lymphocyte vacuolization (HP:6000639)
Antistreptolysin O antibody positivity (HP:6000348)
Antistreptolysin O antibody positivity (HP:6000348)
Positive CSF Borrelia burgdorferi nucleic acid test (HP:6000548)
Positive CSF Borrelia burgdorferi nucleic acid test (HP:6000548)
Scalloped appearance of liver surface (HP:6000628)
Scalloped appearance of liver surface (HP:6000628)
Elevated urinary coproporphyrin level (HP:6000536)
Elevated urinary coproporphyrin level (HP:6000536)
Decreased CSF asialotransferrin to transferrin ratio (HP:6000447)
Decreased CSF asialotransferrin to transferrin ratio (HP:6000447)
Low maternal vitamin B12 concentration (HP:6000518)
Low maternal vitamin B12 concentration (HP:6000518)
Maxillary cyst (HP:6000594)
Maxillary cyst (HP:6000594)
Reduced aspartoacylase activity in cultured fibroblasts (HP:6000354)
Reduced aspartoacylase activity in cultured fibroblasts (HP:6000354)
Elevated circulating complement component concentration (HP:6000474)
Elevated circulating complement component concentration (HP:6000474)
Positive CSF infectious agent test (HP:0430123)
Positive CSF infectious agent test (HP:0430123)
Klazomania (HP:0430111)
Klazomania (HP:0430111)
Elevated urinary beta-alanine level (HP:6000276)
Elevated urinary beta-alanine level (HP:6000276)
Truncal location (HP:6000425)
Truncal location (HP:6000425)
Elevated circulating proinsulin concentration (HP:6000419)
Elevated circulating proinsulin concentration (HP:6000419)
Reduced erythrocyte hexokinase activity (HP:6000559)
Reduced erythrocyte hexokinase activity (HP:6000559)
Positive cutaneous herpes simplex virus nucleic acid test (HP:6000541)
Positive cutaneous herpes simplex virus nucleic acid test (HP:6000541)
Medium vessel vasculitis (HP:6000658)
Medium vessel vasculitis (HP:6000658)
Elevated urine trihydroxycholestanoic acid level (HP:6000393)
Elevated urine trihydroxycholestanoic acid level (HP:6000393)
Reduced circulating adenosine deaminase-2 activity (HP:6000562)
Reduced circulating adenosine deaminase-2 activity (HP:6000562)
Ectopic ureteral orifice (HP:6000413)
Ectopic ureteral orifice (HP:6000413)
Elevated CSF alpha-ketoglutarate concentration (HP:6000468)
Elevated CSF alpha-ketoglutarate concentration (HP:6000468)
Short esophagus (HP:6000382)
Short esophagus (HP:6000382)
Reduced hepatic glyoxylate reductase activity (HP:6000638)
Reduced hepatic glyoxylate reductase activity (HP:6000638)
Thickened mitral valve cusp (HP:6000342)
Thickened mitral valve cusp (HP:6000342)
Hypoechoic breast mass (HP:6000630)
Hypoechoic breast mass (HP:6000630)
Positive CSF varicella zoster virus nucleic acid test (HP:0430138)
Positive CSF varicella zoster virus nucleic acid test (HP:0430138)
Elevated urine mesaconic acid level (HP:6000465)
Elevated urine mesaconic acid level (HP:6000465)
Thoracic cage flatness (HP:6000327)
Thoracic cage flatness (HP:6000327)
Occupational exposure to raw nonsynthetic textiles (HP:6000449)
Occupational exposure to raw nonsynthetic textiles (HP:6000449)
Habitual mouth breathing (HP:6000463)
Habitual mouth breathing (HP:6000463)
Primary peritoneal serous papillary adenocarcinoma (HP:0430116)
Primary peritoneal serous papillary adenocarcinoma (HP:0430116)
Positive synonvial fluid infectious agent test (HP:6000581)
Positive synonvial fluid infectious agent test (HP:6000581)
Elevated CSF cystathionine concentration (HP:6000280)
Elevated CSF cystathionine concentration (HP:6000280)
Elevated urinary succinylaminoimidazole carboxamide riboside level (HP:6000390)
Elevated urinary succinylaminoimidazole carboxamide riboside level (HP:6000390)
Positive Mycobacterium avium sputum culture (HP:0430108)
Positive Mycobacterium avium sputum culture (HP:0430108)
Cardiac valve vegetations (HP:6000326)
Cardiac valve vegetations (HP:6000326)
History of recent stay in area with inadequate sewage sanitation (HP:6000540)
History of recent stay in area with inadequate sewage sanitation (HP:6000540)
Small intestine mass (HP:6000410)
Small intestine mass (HP:6000410)
Elevated circulating complement C3 concentration (HP:0430146)
Elevated circulating complement C3 concentration (HP:0430146)
Reduced criculating stearoylcarnitine concentration (HP:6000437)
Reduced criculating stearoylcarnitine concentration (HP:6000437)
Glomerular immune-complex deposition (HP:6000668)
Glomerular immune-complex deposition (HP:6000668)
Reduced phosphoenolpyruvate carboxykinase activity in cultured fibroblasts (HP:6000619)
Reduced phosphoenolpyruvate carboxykinase activity in cultured fibroblasts (HP:6000619)
Tympanic membrane bulla (HP:6000422)
Tympanic membrane bulla (HP:6000422)
Tachyphagia (HP:6000352)
Tachyphagia (HP:6000352)
Paravertebral mass (HP:6000660)
Paravertebral mass (HP:6000660)
Elevated urinary methylmalonylcarnitine level (HP:6000392)
Elevated urinary methylmalonylcarnitine level (HP:6000392)
Elevated urinary isovalerylglycine level (HP:6000602)
Elevated urinary isovalerylglycine level (HP:6000602)
Left atrial fibrosis (HP:6000691)
Left atrial fibrosis (HP:6000691)
Elevated urine hyaluronic acid level (HP:6000391)
Elevated urine hyaluronic acid level (HP:6000391)
Duplicate uterine cervix (HP:6000414)
Duplicate uterine cervix (HP:6000414)
Elevated urinary ureidoisobutyric acid level (HP:6000622)
Elevated urinary ureidoisobutyric acid level (HP:6000622)
Lipid-laden bone-marrow macrophages (HP:6000640)
Lipid-laden bone-marrow macrophages (HP:6000640)
Burning eye sensation (HP:6000420)
Burning eye sensation (HP:6000420)
Cerebral subcortical cyst (HP:6000461)
Cerebral subcortical cyst (HP:6000461)
Glomerular fibronectin deposits (HP:6000428)
Glomerular fibronectin deposits (HP:6000428)
Elevated circulating 2-trans,4-cis-decadienoylcarnitine concentration (HP:6000478)
Elevated circulating 2-trans,4-cis-decadienoylcarnitine concentration (HP:6000478)
Paraspinal arteriovenous malformation (HP:6000592)
Paraspinal arteriovenous malformation (HP:6000592)
Elevated urine D-lactate level (HP:6000467)
Elevated urine D-lactate level (HP:6000467)
Positive treponema pallidum PCR test in the blood circulation (HP:6000545)
Positive treponema pallidum PCR test in the blood circulation (HP:6000545)
Nipple thickening (HP:6000629)
Nipple thickening (HP:6000629)
Elevated circulating inhibin A concentration (HP:6000519)
Elevated circulating inhibin A concentration (HP:6000519)
Snowflake effect in amniotic cavity (HP:6000341)
Snowflake effect in amniotic cavity (HP:6000341)
Esophageal dilation (HP:6000589)
Esophageal dilation (HP:6000589)
Ductus venosus agenesis with extrahepatic drainage and liver bypass (HP:6000370)
Ductus venosus agenesis with extrahepatic drainage and liver bypass (HP:6000370)
Positive Bartonella henselae nucleic acid test in the blood circulation (HP:6000550)
Positive Bartonella henselae nucleic acid test in the blood circulation (HP:6000550)
Elevated circulating plasminogen activator inhibitor 1 activity (HP:0430125)
Elevated circulating plasminogen activator inhibitor 1 activity (HP:0430125)
Reduced tissue alpha-N-acetylglucosaminidase activity (HP:6000360)
Reduced tissue alpha-N-acetylglucosaminidase activity (HP:6000360)
Elevated urinary N-carbamoyl-beta-alanine level (HP:6000279)
Elevated urinary N-carbamoyl-beta-alanine level (HP:6000279)
Sweating and flushing in the preauricular area in response to mastication (HP:6000637)
Sweating and flushing in the preauricular area in response to mastication (HP:6000637)
Anti-factor X antibody positivity (HP:6000496)
Anti-factor X antibody positivity (HP:6000496)
Elevated CSF ammonia concentration (HP:6000394)
Elevated CSF ammonia concentration (HP:6000394)
Pancreatic mass (HP:6000409)
Pancreatic mass (HP:6000409)
Bladder rupture (HP:6000662)
Bladder rupture (HP:6000662)
Frontal cortical localization (HP:0430128)
Frontal cortical localization (HP:0430128)
Crescent-shaped iliac bone (HP:6000653)
Crescent-shaped iliac bone (HP:6000653)
Elevated circulating CXCL10 concentration (HP:6000486)
Elevated circulating CXCL10 concentration (HP:6000486)
Elevated circulating fibroblast growth factor 23 concentration (HP:6000407)
Elevated circulating fibroblast growth factor 23 concentration (HP:6000407)
Flank mass (HP:6000363)
Flank mass (HP:6000363)
Abnormal metacarpal ossification (HP:6000651)
Abnormal metacarpal ossification (HP:6000651)
Inferior vena cava obstruction (HP:6000417)
Inferior vena cava obstruction (HP:6000417)
Abnormal circulating interleukin 6 concentration (HP:6000441)
Abnormal circulating interleukin 6 concentration (HP:6000441)
Intramural intestinal gas (HP:6000377)
Intramural intestinal gas (HP:6000377)
Reduced tissue arginine:glycine amidinotransferase activity (HP:6000572)
Reduced tissue arginine:glycine amidinotransferase activity (HP:6000572)
Postmenopausal onset (HP:6000315)
Postmenopausal onset (HP:6000315)
Thinned small intestinal mucosa (HP:6000337)
Thinned small intestinal mucosa (HP:6000337)
Abnormal brain-evoked potentials (HP:0430106)
Abnormal brain-evoked potentials (HP:0430106)
Elevated urine 2-trans,4-cis-decadienoylcarnitine level (HP:6000477)
Elevated urine 2-trans,4-cis-decadienoylcarnitine level (HP:6000477)
Reduced tissue acetyl-CoA carboxylase activity (HP:6000430)
Reduced tissue acetyl-CoA carboxylase activity (HP:6000430)
Abnormal circulating CC chemokine concentration (HP:6000446)
Abnormal circulating CC chemokine concentration (HP:6000446)
Elevated urine succinic acid level (HP:0430137)
Elevated urine succinic acid level (HP:0430137)
Elevated CSF dihydrobiopterin concentration (HP:6000690)
Elevated CSF dihydrobiopterin concentration (HP:6000690)
Reduced urinary iodine level (HP:6000438)
Reduced urinary iodine level (HP:6000438)
Persistent falcine venous sinus (HP:6000295)
Persistent falcine venous sinus (HP:6000295)
Anti-intrinsic factor antibody positivity (HP:6000344)
Anti-intrinsic factor antibody positivity (HP:6000344)
Elevated urinary indoleacetic acid level (HP:6000332)
Elevated urinary indoleacetic acid level (HP:6000332)
Autonomic-voluntary dissociation of facial movements (HP:6000306)
Autonomic-voluntary dissociation of facial movements (HP:6000306)
Abnormal circulating plasminogen activator inhibitor 1 activity (HP:0430126)
Abnormal circulating plasminogen activator inhibitor 1 activity (HP:0430126)
Right ventricular regional dyskinesia (HP:6000666)
Right ventricular regional dyskinesia (HP:6000666)
Seminal vesicle hypoplasia (HP:6000338)
Seminal vesicle hypoplasia (HP:6000338)
History of recent iodated contrast medium administration (HP:6000293)
History of recent iodated contrast medium administration (HP:6000293)
Rest limb pain (HP:6000627)
Rest limb pain (HP:6000627)
Elevated circulating cholesterol sulfate concentration (HP:6000565)
Elevated circulating cholesterol sulfate concentration (HP:6000565)
Elevated urinary thymine level (HP:6000331)
Elevated urinary thymine level (HP:6000331)
Impaired heel-walking ability (HP:6000490)
Impaired heel-walking ability (HP:6000490)
Abnormal urinary organic compound level (HP:6000531)
Abnormal urinary organic compound level (HP:6000531)
History of compressive footwear (HP:6000302)
History of compressive footwear (HP:6000302)
Ameliorated by riboflavin (HP:6000373)
Ameliorated by riboflavin (HP:6000373)
Collarettes (HP:6000421)
Collarettes (HP:6000421)
Reduced tissue tissue AICAR transformylase activity (HP:6000349)
Reduced tissue tissue AICAR transformylase activity (HP:6000349)
Reduced circulating interleukin 6 concentration (HP:0430142)
Reduced circulating interleukin 6 concentration (HP:0430142)
Elevated urinary 2-hydroxyisocaproic acid level (HP:6000601)
Elevated urinary 2-hydroxyisocaproic acid level (HP:6000601)
Positive CSF VDRL test (HP:6000395)
Positive CSF VDRL test (HP:6000395)
Unilocular ovarian cyst (HP:6000631)
Unilocular ovarian cyst (HP:6000631)
Anti-D-L antibody positivity (HP:6000387)
Anti-D-L antibody positivity (HP:6000387)
Sonographic renal salt and pepper pattern (HP:6000368)
Sonographic renal salt and pepper pattern (HP:6000368)
Antiparietal cell antibody positivity (HP:6000343)
Antiparietal cell antibody positivity (HP:6000343)
Subcortical localization (HP:0430130)
Subcortical localization (HP:0430130)
Reduced tissue thymidine phosphorylase activity (HP:6000570)
Reduced tissue thymidine phosphorylase activity (HP:6000570)
Nipple epidermal Paget cells (HP:6000624)
Nipple epidermal Paget cells (HP:6000624)
Elevated urinary glycolic acid level (HP:6000431)
Elevated urinary glycolic acid level (HP:6000431)
Bone marrow monocytosis (HP:6000641)
Bone marrow monocytosis (HP:6000641)
Pulmonary perfusion defect (HP:6000412)
Pulmonary perfusion defect (HP:6000412)
Reduced tissue tripeptidyl peptidase 1 activity (HP:6000571)
Reduced tissue tripeptidyl peptidase 1 activity (HP:6000571)
Anti-factor XI antibody positivity (HP:6000497)
Anti-factor XI antibody positivity (HP:6000497)
Positive CSF toxoplasma gondii nucleic acid test (HP:0430124)
Positive CSF toxoplasma gondii nucleic acid test (HP:0430124)
Nasal dermoid cyst (HP:0430145)
Nasal dermoid cyst (HP:0430145)
Non-pitting edema (HP:6000507)
Non-pitting edema (HP:6000507)
Excessive blood loss during delivery (HP:6000325)
Excessive blood loss during delivery (HP:6000325)
Decreased skin turgor (HP:6000303)
Decreased skin turgor (HP:6000303)
Elevated 18-hydroxycorticosterone to aldosterone ratio (HP:6000515)
Elevated 18-hydroxycorticosterone to aldosterone ratio (HP:6000515)
Elevated circulating 2-aminoadipic acid concentration (HP:6000278)
Elevated circulating 2-aminoadipic acid concentration (HP:6000278)
Elevated urinary 7-hydroxyoctanoic acid level (HP:6000605)
Elevated urinary 7-hydroxyoctanoic acid level (HP:6000605)
Elevated urine 2,3-dihydroxy-2-methylbutanoic acid level (HP:6000469)
Elevated urine 2,3-dihydroxy-2-methylbutanoic acid level (HP:6000469)
Retracted tympanic membrane (HP:6000459)
Retracted tympanic membrane (HP:6000459)
Elevated circulating soluble CD163 concentration (HP:6000385)
Elevated circulating soluble CD163 concentration (HP:6000385)
Sixth cranial nerve hypoplasia (HP:6000596)
Sixth cranial nerve hypoplasia (HP:6000596)
Elevated urinary D-glyceric acid level (HP:6000606)
Elevated urinary D-glyceric acid level (HP:6000606)
Positive CSF varicella zoster antibody positivity (HP:0430141)
Positive CSF varicella zoster antibody positivity (HP:0430141)
Elevated circulating C12 acylcarnitine concentration (HP:0430143)
Elevated circulating C12 acylcarnitine concentration (HP:0430143)
Elevated CSF L-2-hydroxyglutaric acid concentration (HP:6000509)
Elevated CSF L-2-hydroxyglutaric acid concentration (HP:6000509)
Ductus venosus agenesis with intrahepatic drainage (HP:6000369)
Ductus venosus agenesis with intrahepatic drainage (HP:6000369)
Positive bloodstream Cysticercosis antigen test (HP:0430110)
Positive bloodstream Cysticercosis antigen test (HP:0430110)
Penis uncircumcised (HP:6000296)
Penis uncircumcised (HP:6000296)
4-5 toe cutaneous syndactyly (HP:6000503)
4-5 toe cutaneous syndactyly (HP:6000503)
Excessive nocturnal light exposure (HP:6000308)
Excessive nocturnal light exposure (HP:6000308)
Abnormal circulating lipoprotein(a) concentration (HP:0430148)
Abnormal circulating lipoprotein(a) concentration (HP:0430148)
Elevated circulating CCL3 concentration (HP:6000687)
Elevated circulating CCL3 concentration (HP:6000687)
Livestock exposure (HP:6000528)
Livestock exposure (HP:6000528)
Serpentine skin location (HP:6000530)
Serpentine skin location (HP:6000530)
Pancreatic intraductal papillary mucinous neoplasm (HP:6000657)
Pancreatic intraductal papillary mucinous neoplasm (HP:6000657)
Elevated urinary 3-hydroxyadipic acid level (HP:6000609)
Elevated urinary 3-hydroxyadipic acid level (HP:6000609)
Elevated thallium cadmiun concentration (HP:6000445)
Elevated thallium cadmiun concentration (HP:6000445)
Positive CSF arbovirus nucleic acid test (HP:6000549)
Positive CSF arbovirus nucleic acid test (HP:6000549)
Synchronous skin lesions (HP:6000529)
Synchronous skin lesions (HP:6000529)
Bulging fontanelle (HP:6000647)
Bulging fontanelle (HP:6000647)
Elevated circulating alpha-ketoglutarate concentration (HP:6000435)
Elevated circulating alpha-ketoglutarate concentration (HP:6000435)
Positive cold agglutinin test (HP:6000386)
Positive cold agglutinin test (HP:6000386)
Reduced tissue argininosuccinate synthetase activity (HP:6000353)
Reduced tissue argininosuccinate synthetase activity (HP:6000353)
Bilioduodenal fistula (HP:6000453)
Bilioduodenal fistula (HP:6000453)
Porcelain gallbladder (HP:6000451)
Porcelain gallbladder (HP:6000451)
Head impulse test has corrective saccade (HP:0430122)
Head impulse test has corrective saccade (HP:0430122)
Anti-von Willebrand factor antibody positivity (HP:6000676)
Anti-von Willebrand factor antibody positivity (HP:6000676)
Retroperitoneal mass (HP:6000285)
Retroperitoneal mass (HP:6000285)
Midline notching of lower lip (HP:6000569)
Midline notching of lower lip (HP:6000569)
Spinal lipoma (HP:6000590)
Spinal lipoma (HP:6000590)
Papillary dermis eosinophilic hyaline material (HP:6000656)
Papillary dermis eosinophilic hyaline material (HP:6000656)
Non-glucose reducing substance in urine (HP:6000389)
Non-glucose reducing substance in urine (HP:6000389)
Brown pigmentation of the conjunctiva (HP:6000365)
Brown pigmentation of the conjunctiva (HP:6000365)
Positive oropharynx poliovirus nucleic acid test (HP:6000580)
Positive oropharynx poliovirus nucleic acid test (HP:6000580)
Decreased Wiskott-Aldrich syndrome protein concentration in hematopoietic cells (HP:6000472)
Decreased Wiskott-Aldrich syndrome protein concentration in hematopoietic cells (HP:6000472)
Radioulnar subluxation (HP:6000506)
Radioulnar subluxation (HP:6000506)
Sulfur-containing abscess (HP:6000458)
Sulfur-containing abscess (HP:6000458)
Occipital cortex localization (HP:0430132)
Occipital cortex localization (HP:0430132)
Elevated circulating lipoprotein X concentration (HP:6000566)
Elevated circulating lipoprotein X concentration (HP:6000566)
Femoral neck fracture (HP:6000655)
Femoral neck fracture (HP:6000655)
Reduced circulating NT-proANP concentration (HP:6000693)
Reduced circulating NT-proANP concentration (HP:6000693)
Synovial cyst (HP:6000364)
Synovial cyst (HP:6000364)
Nasal secretion neutrophilia (HP:0430120)
Nasal secretion neutrophilia (HP:0430120)
Elevated urinary N-carbamyl-beta-aminoisobutyric acid level (HP:6000623)
Elevated urinary N-carbamyl-beta-aminoisobutyric acid level (HP:6000623)
Elevated blood cadmiun concentration (HP:6000444)
Elevated blood cadmiun concentration (HP:6000444)
Localized over bony prominences (HP:6000301)
Localized over bony prominences (HP:6000301)
Brain localization (HP:0430127)
Brain localization (HP:0430127)
Menstruating female between menarche and menopause (HP:6000309)
Menstruating female between menarche and menopause (HP:6000309)
Reduced Inositol polyphosphate 5-phosphatase OCRL-1 activity in cultured fibroblasts (HP:6000615)
Reduced Inositol polyphosphate 5-phosphatase OCRL-1 activity in cultured fibroblasts (HP:6000615)
Gastric volvulus (HP:6000384)
Gastric volvulus (HP:6000384)
History of facial cosmetic use (HP:6000297)
History of facial cosmetic use (HP:6000297)
Diminished circulating reduced nicotinamide adenine dinucleotide (NADH) concentration (HP:6000406)
Diminished circulating reduced nicotinamide adenine dinucleotide (NADH) concentration (HP:6000406)
Mesenteric torsion (HP:6000632)
Mesenteric torsion (HP:6000632)
Reduced circulating protein Z concentration (HP:6000401)
Reduced circulating protein Z concentration (HP:6000401)
Bloodstream Malaria parasite (HP:6000553)
Bloodstream Malaria parasite (HP:6000553)
Low serum osmolality (HP:6000680)
Low serum osmolality (HP:6000680)
Beard and mustache distribution (HP:6000423)
Beard and mustache distribution (HP:6000423)
Preterm premature rupture of membranes (HP:6000310)
Preterm premature rupture of membranes (HP:6000310)
Elevated circulating beta chorionic gonadotropin concentration (HP:6000485)
Elevated circulating beta chorionic gonadotropin concentration (HP:6000485)
Positive CSF mycobacterium tuberculosis nucleic acid test (HP:6000542)
Positive CSF mycobacterium tuberculosis nucleic acid test (HP:6000542)
Anti-lamin A antibody positivity (HP:6000643)
Anti-lamin A antibody positivity (HP:6000643)
Third cranial nerve hypoplasia (HP:6000597)
Third cranial nerve hypoplasia (HP:6000597)
Increased ratio of deoxypyridinoline to pyridinoline cross-links in urine (HP:6000330)
Increased ratio of deoxypyridinoline to pyridinoline cross-links in urine (HP:6000330)
Reduced muscle glycogen debrancher enzyme activity (HP:6000616)
Reduced muscle glycogen debrancher enzyme activity (HP:6000616)
Reduced sepiapterin reductase activity in cultured fibroblasts (HP:6000563)
Reduced sepiapterin reductase activity in cultured fibroblasts (HP:6000563)
Spastic monoplegia (HP:6000316)
Spastic monoplegia (HP:6000316)
Gallbladder adhesions (HP:6000452)
Gallbladder adhesions (HP:6000452)
Radiating pain (HP:6000684)
Radiating pain (HP:6000684)
Abnormal CSF N-acetylaspartic acid concentration (HP:6000673)
Abnormal CSF N-acetylaspartic acid concentration (HP:6000673)
Absent axon flare response after intradermal histamine injection (HP:6000322)
Absent axon flare response after intradermal histamine injection (HP:6000322)
Elevated urinary butyric acid level (HP:6000433)
Elevated urinary butyric acid level (HP:6000433)
Anti-annexin A5 antibody positivity (HP:6000646)
Anti-annexin A5 antibody positivity (HP:6000646)
Reduced hepatic ornithine transcarbamylase activity (HP:6000334)
Reduced hepatic ornithine transcarbamylase activity (HP:6000334)
Elevated erythrocyte galactose-1-phosphate concentration (HP:6000610)
Elevated erythrocyte galactose-1-phosphate concentration (HP:6000610)
Elevated urinary 2-oxoisocaproic level (HP:6000599)
Elevated urinary 2-oxoisocaproic level (HP:6000599)
Skip lesions on temporal artery biopsy (HP:0430105)
Skip lesions on temporal artery biopsy (HP:0430105)
Aplasia/hypoplasia of the uterine cervix (HP:0430114)
Aplasia/hypoplasia of the uterine cervix (HP:0430114)
Reduced circulating insulin-like growth factor 2 concentration (HP:6000404)
Reduced circulating insulin-like growth factor 2 concentration (HP:6000404)
Reduced neutrophil myeloperoxidase activity (HP:6000375)
Reduced neutrophil myeloperoxidase activity (HP:6000375)
Elevated CSF guanidinoacetic acid concentration (HP:6000396)
Elevated CSF guanidinoacetic acid concentration (HP:6000396)
Elevated urinary L-glycerate level (HP:6000670)
Elevated urinary L-glycerate level (HP:6000670)
Reduced tissue gamma-glutamyltransferase activity (HP:6000578)
Reduced tissue gamma-glutamyltransferase activity (HP:6000578)
Elevated circulating 27-hydroxycholesterol concentration (HP:6000402)
Elevated circulating 27-hydroxycholesterol concentration (HP:6000402)
Elevated circulating 21-deoxycortisol concentration (HP:6000516)
Elevated circulating 21-deoxycortisol concentration (HP:6000516)
Right ventricular aneurysm (HP:6000667)
Right ventricular aneurysm (HP:6000667)
Sputum infectious agent (HP:0430107)
Sputum infectious agent (HP:0430107)
Ruffled acrosome (HP:6000501)
Ruffled acrosome (HP:6000501)
Facial nerve compression (HP:6000411)
Facial nerve compression (HP:6000411)
Elevated urine manganese level (HP:6000480)
Elevated urine manganese level (HP:6000480)
Abnormal circulating atrial natriuretic peptide pro-hormone concentration (HP:6000692)
Abnormal circulating atrial natriuretic peptide pro-hormone concentration (HP:6000692)
Abnormal circulating fibroblast growth factor 23 concentration (HP:6000489)
Abnormal circulating fibroblast growth factor 23 concentration (HP:6000489)
Positive blood infectious agent test (HP:0430150)
Positive blood infectious agent test (HP:0430150)
Rib spur (HP:6000652)
Rib spur (HP:6000652)
Reduced circulating lipoprotein(a) concentration (HP:6000522)
Reduced circulating lipoprotein(a) concentration (HP:6000522)
Failure to elevate ammonia on ischemic exercise (HP:6000320)
Failure to elevate ammonia on ischemic exercise (HP:6000320)
Reduced cystathionine beta-synthase activity in cultured fibroblasts (HP:6000357)
Reduced cystathionine beta-synthase activity in cultured fibroblasts (HP:6000357)
Reduced CSF asparagine concentration (HP:6000408)
Reduced CSF asparagine concentration (HP:6000408)
Reduced malonyl-CoA decarboxylase activity in cultured fibroblasts (HP:6000355)
Reduced malonyl-CoA decarboxylase activity in cultured fibroblasts (HP:6000355)
Positive skin infectious agent test (HP:0430117)
Positive skin infectious agent test (HP:0430117)
Temporal artery giant cells (HP:6000618)
Temporal artery giant cells (HP:6000618)
Reduced hepatic phosphorylase kinase activity (HP:6000333)
Reduced hepatic phosphorylase kinase activity (HP:6000333)
Periosteal elevation (HP:6000588)
Periosteal elevation (HP:6000588)
Reduced erythrocyte bisphosphoglycerate mutase activity (HP:6000557)
Reduced erythrocyte bisphosphoglycerate mutase activity (HP:6000557)
Elevated urinary 3-hydroxypentanoic acid level (HP:6000604)
Elevated urinary 3-hydroxypentanoic acid level (HP:6000604)
Empty sella turcica (HP:6000483)
Empty sella turcica (HP:6000483)
Elevated aldosterone:renin ratio (HP:6000318)
Elevated aldosterone:renin ratio (HP:6000318)
Reduced tissue 3-methylglutaconyl-CoA hydratase activity (HP:6000577)
Reduced tissue 3-methylglutaconyl-CoA hydratase activity (HP:6000577)
Decreased circulating carboxypeptidase N activity (HP:6000560)
Decreased circulating carboxypeptidase N activity (HP:6000560)
History of recent cat bite (HP:6000539)
History of recent cat bite (HP:6000539)
Positive CSF pathogen-specific antibody positivity (HP:0430139)
Positive CSF pathogen-specific antibody positivity (HP:0430139)
Mitral opening snap (HP:6000685)
Mitral opening snap (HP:6000685)
Decreased erythrocyte fructose-1,6-bisphosphate aldolase activity (HP:6000555)
Decreased erythrocyte fructose-1,6-bisphosphate aldolase activity (HP:6000555)
Elevated tissue sphingomyelin concentration (HP:6000292)
Elevated tissue sphingomyelin concentration (HP:6000292)
Rokitansky-Aschoff gallbladder sinuses (HP:6000450)
Rokitansky-Aschoff gallbladder sinuses (HP:6000450)
Fetal oral mass (HP:6000470)
Fetal oral mass (HP:6000470)
Anti-factor V antibody positivity (HP:6000492)
Anti-factor V antibody positivity (HP:6000492)
Mandibular cyst (HP:6000595)
Mandibular cyst (HP:6000595)
Positive synonvial fluid culture (HP:6000582)
Positive synonvial fluid culture (HP:6000582)
Elevated circulating tetradecenoylcarnitine concentration (HP:6000476)
Elevated circulating tetradecenoylcarnitine concentration (HP:6000476)
Elevated urinary N-methylhistamine level (HP:6000533)
Elevated urinary N-methylhistamine level (HP:6000533)
Abnormal superficial temporal artery morphology (HP:0430104)
Abnormal superficial temporal artery morphology (HP:0430104)
Abnormal circulating inhibin B concentration (HP:0430147)
Abnormal circulating inhibin B concentration (HP:0430147)
Squared off shoulders (HP:6000464)
Squared off shoulders (HP:6000464)
Elevated circulating chitotriosidase activity (HP:6000611)
Elevated circulating chitotriosidase activity (HP:6000611)
Reduced erythrocyte glutathione reductase activity (HP:6000525)
Reduced erythrocyte glutathione reductase activity (HP:6000525)
Triggered by overhead motions (HP:6000683)
Triggered by overhead motions (HP:6000683)
Reduced circulating 6-pyruvoyltetrahydropterin synthase activity (HP:6000575)
Reduced circulating 6-pyruvoyltetrahydropterin synthase activity (HP:6000575)
Elevated urinary mevalonate lactone level (HP:6000675)
Elevated urinary mevalonate lactone level (HP:6000675)
Elevated CSF D-glyceric acid concentration (HP:6000372)
Elevated CSF D-glyceric acid concentration (HP:6000372)
Elevated urinary 2-oxovaleric acid level (HP:6000600)
Elevated urinary 2-oxovaleric acid level (HP:6000600)
Triangular nail (HP:6000649)
Triangular nail (HP:6000649)

Every class is written twice. PR implementing code for this result: #719

[hrshdhgd]

In the code, the first if condition that is satisfied:

          if stanza1 is None:
            stanza1 = Stanza(id=stanza2.id, type=stanza2.type)
            if stanza2.type == "Term":
                yield kgcl.ClassCreation(id=_id(), about_node=stanza2.id)
            elif stanza2.type == "Typedef":
                yield kgcl.NodeCreation(id=_id(), about_node=stanza2.id)
            else:
                raise ValueError(f"Unknown stanza type: {stanza2.type}")

and the second if condition satisfied later for the same iteration:

             if tag == TAG_NAME:
                if node_is_deleted:
                    continue
                if vals1 and vals2:
                    yield kgcl.NodeRename(
                        id=_id(), about_node=t1id, new_value=vals2list[0], old_value=vals1list[0]
                    )
                elif vals1:
                    yield kgcl.NodeDeletion(id=_id(), about_node=t1id)
                else:
                    yield kgcl.ClassCreation(id=_id(), about_node=t2id, name=vals2list[0])

[hrshdhgd]

Thoughts @cmungall

I'm thinking of :

          if stanza1 is None:
            stanza1 = Stanza(id=stanza2.id, type=stanza2.type)
            if stanza2.type == "Term":
                # yield kgcl.ClassCreation(id=_id(), about_node=stanza2.id)
                pass
            elif stanza2.type == "Typedef":
                yield kgcl.NodeCreation(id=_id(), about_node=stanza2.id)
            else:
                raise ValueError(f"Unknown stanza type: {stanza2.type}")

[hrshdhgd]

The above solution seems to break tests so I'm going to wait on this one and close the PR linked above.

[anitacaron]

Hi @hrshdhgd, any update on this issue? 😃

[hrshdhgd]

Hey @anitacaron , I'm on parental leave until Monday next week. Will look into this then. Sorry for the delay

[hrshdhgd]

Hey @anitacaron , the issue should be resolved with oaklib v0.6.10. Please confirm so I can close this issue.

[anitacaron]

Thanks, @hrshdhgd. I just tested it, and it's working well. However, the output has another issue with the Mappings added and removed sections. I'll create an issue for this.

[hrshdhgd]

Sounds good, please tag me in the issue !